GERN Q1 2018 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$318,000-40.8% YoY

Gross Profit

-$2M-493.4% margin

Operating Income

-$7M-2338.7% margin

Net Income

-$7M-2259.7% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+66.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$106M

Total Liabilities

$4M

Stockholders' Equity

$101M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$318,000	$537,000	-40.8%
Gross Profit	-$2M	-$2M	+23.4%
Operating Income	-$7M	-$7M	+0.8%
Net Income	-$7M	-$7M	-0.0%